Results 261 to 270 of about 101,746 (297)

Vasodilator system for the face [PDF]

open access: possibleJournal of Neurosurgery, 1975
✓ The authors describe investigations in cats to delineate a vasodilator system to the face, which they undertook after a previous study showed that radiofrequency coagulation of the trigeminal ganglion produced a pronounced flush in the skin of the corresponding division.
Burton M. Onofrio   +2 more
openaire   +2 more sources

Mechanisms of vasodilation

The American Journal of Medicine, 1983
Abstract A variety of factors interact to regulate vascular tone and thereby control blood flow to the regional circulations. The influx of calcium into vascular smooth muscle initiates contraction by binding to calmodulin and stimulating myosin light chain kinase.
openaire   +2 more sources

VASODILATORS IN MECHANICAL VENTILATION

Critical Care Clinics, 1998
Vasodilators that affect the pulmonary vasculature are appealing adjuncts in many cardiopulmonary conditions that require mechanical ventilation such as ARDS, COPD, PPHN, and cardiothoracic surgery. The adverse systemic effects of parenteral PGE1 and parenteral prostacyclin limit their usefulness in critically ill patients.
Nicola A. Hanania, Janice L. Zimmerman
openaire   +3 more sources

Paradoxical Response to the Vasodilators

Angiology, 1982
A 52-year-old male was admitted to the hospital in congestive heart failure. Mitral stenosis as well as an aortic valve prosthesis were the underlying cardiac abnormalities. A Swan-Ganz catheter was inserted and various vasodilators were administered.
Lawrence Gould   +3 more
openaire   +3 more sources

Vasodilator therapy

The American Journal of Medicine, 1986
Vasodilators are a group of drugs with various degrees of arteriolar or venous dilatation used in the treatment of congestive heart failure when symptoms persist after digoxin and diuretic therapy. Nitrates and captopril provide the most consistent improvement in symptoms. Reduced mortality rates in congestive heart failure with vasodilator therapy has
openaire   +2 more sources

Relaxin is a vasodilator hormone [PDF]

open access: possibleAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
relaxin is a polypeptide hormonestructurally related to insulin and the insulin-like growth factors (IGFs). There are two biologically active human relaxins, H1 and H2. Both are expressed in the decidua, placenta, and prostate gland.
Skøtt, O., Carter, A.M.
openaire   +2 more sources

Intercellular signal for vasodilation [PDF]

open access: possibleScience, 2017
Vascular Biology Vasoconstriction must be balanced with vasodilation in the arterioles that supply tissues with blood. The second messenger IP3 has been thought to be the signal that passes from smooth muscle cells through gap junctions to endothelial cells to trigger vasodilation. However, Garland et al.
openaire   +2 more sources

Vasodilating Mechanisms of Testosterone

Experimental and Clinical Endocrinology & Diabetes, 2007
The increased incidence of cardiovascular disease in man compared with premenopausal women suggests an unfavourable effect of male sex hormone testosterone on the cardiovascular system. However, numerous clinical and epidemiological studies reported a controversial relationship between testosterone and cardiovascular disease. Furthermore, an increasing
Melik Seyrek, Oguzhan Yildiz
openaire   +3 more sources

Nifedipine: A Novel Vasodilator

Drugs, 2006
Nifedipine was synthesized by Bayer Germany in 1966 and considered for clinical use as a coronary vasodilator in patients with angina pectoris. Japanese investigators played a great part in the pre-clinical and clinical development of nifedipine. Professor Hashimoto demonstrated that nifedipine could increase coronary blood flow even in extremely low ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy